Supplementary Files
Keywords
antihistamines
epidemiology
chronic urticaria
How to Cite
Plaudit
Abstract
Background: Current information on the particular features of patients suffering chronic spontaneous urticaria refractory to treatment is limited.
Objective: To investigate demographic and clinical characteristics in patients with refractory chronic spontaneous urticaria.
Material and methods: A retrospective analysis of the clinical and demographic information of patients consulting Allergy services from two hospitals in Caracas, Venezuela, who presented spontaneous urticaria lasting more than 6 weeks and did not respond to, at least, one course of treatment with antihistamines.
Results: Refractory chronic spontaneous urticaria was frequent in Hispanic female patients aged 20 to 59 years, with moderate symptoms, individual lesions lasting less than three hours, and wheal diameters between 1 and 3 cm. Angioedema, alone or associated to urticaria was present in 14% of the patients. Most frequent comorbidities were asthma, rhinitis and rhinosinusitis, thyroid diseases and hypertension.
Conclusion: Refractory chronic spontaneous urticaria constitutes a highly prevalent subgroup of chronic urticaria which represents an important therapeutic challenge. This study did not demonstrate differential characteristics distinguishing refractory chronic spontaneous urticaria from chronic spontaneous urticaria patients who respond to the treatment with antihistamines.
References
Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, et al. Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. Allergy 2014;69:1-29.
Greaves MW. Chronic urticaria. N Engl J Med 1995;332:1767-1772.
Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Treatment of recalcitrant chronic urticaria with nonsedating antihistamines: is there evidence for updosing? J Investig Allergol Clin Immunol 2013;23:141-144.
Sánchez-Borges M, Ansotegui I, Jimenez JM, Rojo MI, et al. Comparative efficacy of non-sedating antihistamine updosing in patients with chronic urticaria. World Allergy Organ J 2014;7:33.
Kaplan AP. Treatment of chronic spontaneous urticaria. Allergy Asthma Immunol Res 2012;4:326-331.
Sánchez-Borges M, Asero R, Ansotegui IJ, Baiardini I, WAO Scientific and Clinical Issues Council, et al. Diagnosis and treatment of urticaria and angioedema: a worldwide perspective. World Allergy Organ J 2012;5:125-147.
Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Subtypes of chronic urticaria in patients attending allergy clinics in Venezuela. Eur Ann Allergy Clin Immunol 2014;46:210-215.
Mathias SD, Crosby RD, Zazzali JL, Maurer M, Saini SS. Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2012;108:20-24.
Nebiolo F, Bergia R, Bommarito L, Bugiani M, et al. Effect of arterial hypertension on chronic urticaria duration. Ann Allergy Asthma Immunol 2009;103:407-410.
Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A, González-Aveledo L. Aspirin-exacerbated cutaneous disease (AECD) is a distinct subphenotype of chronic spontaneous urticaria. J Eur Acad Dermatol Venereol 2015;29:698-701.
Larenas-Linnemann D, Medina-Ávalos MA, Ortega-Martell JA, Beirana-Palencia AM, et al. Mexican guidelines on the diagnosis and treatment of urticaria. Rev Alerg Mex 2014;61:118-193.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2015 Revista Alergia México